No more needle pricks, oral drug for kids below 6 with TB gets approval
Thursday, 11 April 2024 ()
Approval of Delamanid for children under 5 in India signifies a major leap in paediatric TB treatment, replacing injectables with severe side effects. The update brings relief to young patients, offering an all-oral regimen for drug-resistant TB.
|
||||
You Might Like |
||||
